KHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kraft Heinz Co (KHC) is not a strong buy for a beginner, long-term investor at this time. The stock is facing significant headwinds, including declining financial performance, bearish technical indicators, and negative sentiment from hedge funds and analysts. While the company has made some positive moves, such as the NFL partnership and product innovation, these are overshadowed by ongoing challenges in revenue growth, profitability, and volume pressures. Given the investor's preference for long-term stability, it is better to hold off on investing in KHC until there are clearer signs of a turnaround.
The technical indicators for KHC are bearish. The MACD is negatively expanding, the RSI is neutral but leaning towards oversold, and the moving averages indicate a downward trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the next support at 21.304. Overall, the technical outlook suggests continued weakness in the stock.
Kraft Heinz announced a five-year global condiment partnership with the NFL, enhancing brand visibility.
Launch of PowerMac, a high-protein pasta product, to cater to health-conscious consumers.
Potential for future consolidation in the food sector, as indicated by recent merger discussions with Unilever.
Hedge funds are selling, with a 136.56% increase in selling activity over the last quarter.
Declining financial performance in Q4 2025, with revenue down 3.38% YoY, net income down 69.45% YoY, and EPS down 68.75% YoY.
Analysts have lowered price targets and ratings, with several firms expressing concerns about ongoing volume challenges and limited visibility into a durable turnaround.
The indefinite pause in the company's separation process has added uncertainty to its strategic direction.
Kraft Heinz's financial performance in Q4 2025 was weak. Revenue dropped by 3.38% YoY to $6.35 billion, net income fell by 69.45% YoY to $651 million, and EPS declined by 68.75% YoY to $0.55. Gross margin also decreased to 33.07%, down 3.87% YoY. These metrics indicate significant challenges in profitability and growth.
Analyst sentiment is predominantly negative. Recent downgrades include JPMorgan lowering its rating to Underweight with a price target of $22, and BNP Paribas also rating it Underperform. While some firms like UBS and Barclays raised their price targets slightly to $25, the overall tone reflects concerns about ongoing volume challenges, increased investments, and limited visibility into a turnaround. The consensus is cautious, with most analysts maintaining Neutral or Underperform ratings.
